Book of Abstracts - Ruhr-Universität Bochum

Book of Abstracts - Ruhr-Universität Bochum Book of Abstracts - Ruhr-Universität Bochum

ruhrunibochum
from ruhrunibochum More from this publisher
19.11.2012 Views

OP-11 ISBOMC `10 5.7 – 9.7. 2010 Ruhr-Universität Bochum Influence of the Rhenium-Platinum antitumor system on tumor growth and blood antioxidant state Nataliia I. Shtemenko, a Alexander V. Shtemenko b a Department of Biophysics and Biochemistry, Dnipropetrovs’k National University, 72 Gagarin avenue, Dnipropetrovs’k 49010, Ukraine, b Department of Inorganic Chemistry, Ukrainian State Chemical Technological University, Gagarin avenue 8, Dnipropetrovs’k 49005, Ukraine. E-mail: ashtemenko@yahoo.com The novel antitumor system including cluster rhenium compounds and cisplatin (Re-Pt 4:1 system) has been recently presented 1 that was effective in the model of rat’s specific Guerink carcinoma T8 and in the majority of experiments led to disappearance of cancer cells. The approach to circumvent such drawbacks of the drugs on the base of heavy metal compounds as dose-limiting toxicities (nephro-, hepato-, neurotoxicity, etc.) by encapsulation of the drug into a nanoparticle prevents byside interactions is a very promising strategy in medicine 2 . Oxidative stress-induced activation of NADPH oxidase and peroxisome proliferators-activated receptors, alterations of redox state of binding proteins, DNA mutations and induction of early response genes and hematopoietic activation, etc. seem to be common elements in the induction of hyperplasia, neoplasia, cancer metastasis, and angiogenesis. In the present work we show application of different nano-preparations of 20 – 100 nm size, nanoliposomes and solid nanoparticles loaded with Re-Pt system or with its components in different ratios in the model of tumor growth. The cluster rhenium compounds dichlorotetra-�isobutiratodirhenium(III) [Re2(i-C3H7CO2)4Cl2] (Re1) and cis-Re2(C10H15COO)2Cl4·2(CH3)2SO (Re2) tetrachlorodi-µ-adamantylcarboxylatodirhenium(III) with dimethyl sulfoxide as axial ligands were the matter of concern. Parameters of oxidative stress in blood of experimental animals were measured. Intensity of peroxide oxidation process (POL), activity of catalase (C) and superoxide dismutase (SOD) in plasma and red blood cells were very sensitive to tumor growth and to its prevention by the system. Introduction of the Re-Pt system in nanoliposomes and nanoparticles did not influence on the inhibition of tumor growth, except experiments, where quantity of cisplatin in capsules were lower (1:8). The lowering of the size of the introduced liposomes and particles did not influence on the intensity of POL: concentration of malonic dialdehyde was not changed. Activities of SOD and C in plasma and erythrocytes were higher, especially in experiments with solid nanoparticles (in 1.8 times in comparison with application of ordinary liposomes). This activation of the antioxidant enzymes was independent from the size of the tumor and remained on the high level even in those experiments, where ratio of introduced Rhenium compound : cisplatin was 1 : 8. In this work we show also that influence of rhenium compounds on the enzymes activity is dependent from the structure of organic radical in the investigated rhenium substance. Encapsulation of the rhenium substances (first component) into lipid coating is effective as in form of liposomes, as in form of nanoparticles; the Re-Pt system is effective in the form of nanoliposomes with mixed composition inside (encapsulation of both components) that opens great opportunities to use medicines with different properties and in ratio of personal inquire in one preparation. Elaboration of solid nanoparticles formulations of the Re-Pt requires additional investigations as on this stage of development of the idea it is clear that only one component of the system may be effectively included into solid lipid coating. Encapsulation of both components is promising, but requires additional procedures warranting prevention of the interactions between cisPt and rhenium compounds. Encapsulation of the Re-Pt antitumor system in nanoparticles and nanoliposomes resulted in active antyhemolytic properties of the systems and activated the specific antioxidant defence. References 1. (a) N. Shtemenko, P. Collery, A. Shtemenko. Anticancer Res. 2007, 27, 2487-2492. (b) A. Shtemenko, P. Collery, N. Shtemenko, K. Domasevitch, et al. Dalton Trans. 2009, 26, 5132 - 5136. 2. (a) C. Medina, M.J Santos-Martinez, A. Radomski. British Journal of Pharmacology, 2007, 150, 552-558. (b) K. N. J. Burger, R.W. H. M. Staffhorst. Nat. Med., 2002, 8, 81-84. 27

OP-12 ISBOMC `10 5.7 – 9.7. 2010 Ruhr-Universität Bochum The [CpM(CO)3] - Moiety (M = Mn, Tc, Re) as Phenyl Ring analog – a Promising Strategy Towards New Drugs and Radiopharmaceuticals D. Can, H.P. N'Dongo, P. Schmutz and R. Alberto* University of Zurich, Faculty of Inorganic Chemistry, Winterthurerstrasse 190, 8057 Zurich, Switzerland. E-mail: daniel.can@aci.uzh.ch Structural changes imposed on proteins or nucleic acids by metal cations such as Ca 2+ or Zn 2+ are essential for the initiation of biological processes. Organometallic complexes are comparably rare as structural recognition site in receptors, whereas exactly this is how most organic molecules and drugs tend to work 1 . As early as 1979 Hanzlik et al. studied the interaction of �-Ferrocenylalanine with phenylalanine hydroxylase and phenylalanine decarboxylase and showed that the ferrocene derivative behaved like phenylalanine analogues 2 . Ongoing investigations by Jaouen et al. showed years later, that substitution of a phenyl ring in tamoxifen by ferrocene similarly kept the biological activity of the lead compound intact 3 . As 99m Tc is nowadays in the focus of the development of radiotracers, introducing group 7 transition metals as [CpM(CO)3] into this analogy opens new directions not only towards new drugs but also towards very promising radiopharmaceuticals. O N H Following this strategy we will present the analogy of different classes of bioactive compounds containing [CpRe(CO)3]: sulphonamides acting as carbonic anhydrase inhibitors with high binding affinities 5 , histone deacetylase inhibitors, amino acids transported by the LAT1 transporter and melanoma imaging agents with melanin afiinity. Herein we describe the synthesis and characterization of "cold" Re-compounds as surrogates to well known pharmaceuticals and discuss their analogy. For the "hot" molecules, we followed a general aqueous approach towards 99m Tc(CO)3 labeled � 5 -Cp derivatives from their dimeric Cp species via metal mediated retro-Diels-Alder reaction 4 and show that the conditions used can be applied to a variety of functional groups. References N OC Re O CO CO N H N 1. S. J. Lippard, J. M. Berg, Principles of Bioinorganic Chemistry, University Science Books, Mill Valley, CA, 1994 2. R. P. Hanzlik, P. Soine, W. H. Soine, J. Med. Chem., 1979, 22, 424-428 3. G. Jaouen, S. Top, A. Vessière, Bioorganometallics, Wiley-VCH, Weinheim, 2006, p. 65 4. Y. Liu, B. Spingler, P. Schmutz et al, J. Am. Chem. Soc., 2008, 130, 1554-1555 5. C. T. Supuran, Nature, 2008, 7, 168-181 28

OP-12<br />

ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />

The [CpM(CO)3] - Moiety (M = Mn, Tc, Re) as Phenyl Ring analog – a Promising<br />

Strategy Towards New Drugs and Radiopharmaceuticals<br />

D. Can, H.P. N'Dongo, P. Schmutz and R. Alberto*<br />

University <strong>of</strong> Zurich, Faculty <strong>of</strong> Inorganic Chemistry, Winterthurerstrasse 190, 8057 Zurich,<br />

Switzerland.<br />

E-mail: daniel.can@aci.uzh.ch<br />

Structural changes imposed on proteins or nucleic acids by metal cations such as Ca 2+ or Zn 2+ are<br />

essential for the initiation <strong>of</strong> biological processes. Organometallic complexes are comparably rare as<br />

structural recognition site in receptors, whereas exactly this is how most organic molecules and drugs<br />

tend to work 1 .<br />

As early as 1979 Hanzlik et al. studied the interaction <strong>of</strong> �-Ferrocenylalanine with phenylalanine<br />

hydroxylase and phenylalanine decarboxylase and showed that the ferrocene derivative behaved like<br />

phenylalanine analogues 2 . Ongoing investigations by Jaouen et al. showed years later, that substitution<br />

<strong>of</strong> a phenyl ring in tamoxifen by ferrocene similarly kept the biological activity <strong>of</strong> the lead compound<br />

intact 3 .<br />

As 99m Tc is nowadays in the focus <strong>of</strong> the development <strong>of</strong> radiotracers, introducing group 7 transition<br />

metals as [CpM(CO)3] into this analogy opens new directions not only towards new drugs but also<br />

towards very promising radiopharmaceuticals.<br />

O<br />

N<br />

H<br />

Following this strategy we will present the analogy <strong>of</strong> different classes <strong>of</strong> bioactive compounds<br />

containing [CpRe(CO)3]: sulphonamides acting as carbonic anhydrase inhibitors with high binding<br />

affinities 5 , histone deacetylase inhibitors, amino acids transported by the LAT1 transporter and<br />

melanoma imaging agents with melanin afiinity.<br />

Herein we describe the synthesis and characterization <strong>of</strong> "cold" Re-compounds as surrogates to well<br />

known pharmaceuticals and discuss their analogy. For the "hot" molecules, we followed a general<br />

aqueous approach towards 99m Tc(CO)3 labeled � 5 -Cp derivatives from their dimeric Cp species via<br />

metal mediated retro-Diels-Alder reaction 4 and show that the conditions used can be applied to a<br />

variety <strong>of</strong> functional groups.<br />

References<br />

N<br />

OC<br />

Re<br />

O<br />

CO<br />

CO<br />

N<br />

H<br />

N<br />

1. S. J. Lippard, J. M. Berg, Principles <strong>of</strong> Bioinorganic Chemistry, University Science <strong>Book</strong>s, Mill<br />

Valley, CA, 1994<br />

2. R. P. Hanzlik, P. Soine, W. H. Soine, J. Med. Chem., 1979, 22, 424-428<br />

3. G. Jaouen, S. Top, A. Vessière, Bioorganometallics, Wiley-VCH, Weinheim, 2006, p. 65<br />

4. Y. Liu, B. Spingler, P. Schmutz et al, J. Am. Chem. Soc., 2008, 130, 1554-1555<br />

5. C. T. Supuran, Nature, 2008, 7, 168-181<br />

28

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!